Another factor that can be significant is the institutional framework. In the biotechnology field, for instance, Jones (2000) note that in recent years the increased emphasis on outsourcing on the part of large pharmaceutical companies has made them keen to buy in knowledge, rather than invest directly in R&D, thereby creating opportunities for small biotechnology companies.